Janus Henderson Group
UTHR icon

Janus Henderson Group’s United Therapeutics UTHR Stock Holding History

Janus Henderson Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$514M Buy
866,930
+70,829
+9% +$35.3M 0.25% 97
2025
Q4 		$388M Buy
796,101
+341,383
+75% +$159M 0.17% 127
2025
Q3 		$191M Buy
454,718
+173,195
+62% +$58.2M 0.09% 188
2025
Q2 		$80.9M Buy
281,523
+90,134
+47% +$26.9M 0.04% 303
2025
Q1 		$58.7M Sell
191,389
-277,607
-59% -$95.1M 0.03% 340
2024
Q4 		$165M Buy
468,996
+8,577
+2% +$3.15M 0.08% 213
2024
Q3 		$165M Buy
460,419
+50,409
+12% +$17M 0.08% 211
2024
Q2 		$131M Sell
410,010
-225,337
-35% -$59.6M 0.07% 231
2024
Q1 		$146M Sell
635,347
-234,772
-27% -$53M 0.08% 221
2023
Q4 		$191M Sell
870,119
-6,449
-0.7% -$1.49M 0.11% 186
2023
Q3 		$198M Sell
876,568
-2,276
-0.3% -$524K 0.13% 169
2023
Q2 		$194M Sell
878,844
-96,986
-10% -$21.5M 0.12% 169
2023
Q1 		$219M Buy
975,830
+208,404
+27% +$51.4M 0.14% 152
2022
Q4 		$213M Sell
767,426
-882,216
-53% -$223M 0.15% 152
2022
Q3 		$345M Buy
1,649,642
+941,837
+133% +$211M 0.13% 172
2022
Q2 		$167M Buy
707,805
+94,843
+15% +$19.3M 0.12% 188
2022
Q1 		$110M Buy
612,962
+544,649
+797% +$104M 0.05% 295
2021
Q4 		$14.8M Buy
68,313
+60,658
+792% +$11.9M 0.01% 849
2021
Q3 		$1.41M Buy
+7,655
New +$1.51M ﹤0.01% 1314
2021
Q2 		– Sell
-12,691
Closed -$2.12M – 1677
2021
Q1 		$2.12M Sell
12,691
-6,074
-32% -$1.01M ﹤0.01% 1178
2020
Q4 		$2.85M Sell
18,765
-8,287
-31% -$1.09M ﹤0.01% 1071
2020
Q3 		$2.73M Buy
27,052
+11,809
+77% +$1.3M ﹤0.01% 1009
2020
Q2 		$1.84M Buy
15,243
+7,818
+105% +$880K ﹤0.01% 1042
2020
Q1 		$704K Sell
7,425
-48
-0.6% -$4.56K ﹤0.01% 1144
2019
Q4 		$658K Buy
7,473
+2,501
+50% +$220K ﹤0.01% 1270
2019
Q3 		$397K Buy
4,972
+830
+20% +$66.8K ﹤0.01% 1307
2019
Q2 		$323K Sell
4,142
-9,531
-70% -$891K ﹤0.01% 1311
2019
Q1 		$1.6M Sell
13,673
-6,172
-31% -$719K ﹤0.01% 1148
2018
Q4 		$2.16M Buy
19,845
+7,033
+55% +$815K ﹤0.01% 1096
2018
Q3 		$1.64M Sell
12,812
-4,293
-25% -$531K ﹤0.01% 1210
2018
Q2 		$1.94M Sell
17,105
-25,206
-60% -$2.77M ﹤0.01% 1170
2018
Q1 		$4.75M Buy
42,311
+4,685
+12% +$595K ﹤0.01% 1017
2017
Q4 		$5.57M Sell
37,626
-8,920
-19% -$1.13M ﹤0.01% 966
2017
Q3 		$5.46M Sell
46,546
-23,478
-34% -$3M ﹤0.01% 966
2017
Q2 		$9.08M Buy
70,024
+65,560
+1,469% +$8.18M 0.01% 888
2017
Q1 		$604K Hold
4,464
– – ﹤0.01% 755
2016
Q4 		$640K Buy
4,464
+600
+16% +$76.6K ﹤0.01% 760
2016
Q3 		$456K Hold
3,864
– – ﹤0.01% 776
2016
Q2 		$409K Hold
3,864
– – ﹤0.01% 770
2016
Q1 		$430K Hold
3,864
– – ﹤0.01% 774
2015
Q4 		$605K Hold
3,864
– – ﹤0.01% 726
2015
Q3 		$507K Hold
3,864
– – ﹤0.01% 741
2015
Q2 		$672K Buy
+3,864
New +$695K 0.01% 747

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Janus Henderson Group's UTHR Position: Q1 2026 in Review

Janus Henderson Group increased its United Therapeutics (UTHR) stake by 8.9% in Q1 2026, buying an estimated $35.3M and bringing the position to 866,930 shares worth $514M. The position accounts for 0.25% of the portfolio, ranked #97.

Janus Henderson Group first reported a position in UTHR in Q2 2015 and has held it in 43 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Janus Henderson Group held 866,930 shares of United Therapeutics worth $514M as of Q1 2026.
  • Janus Henderson Group bought 70,829 United Therapeutics shares in Q1 2026, an estimated $35.3M.
  • United Therapeutics made up 0.25% of Janus Henderson Group's portfolio in Q1 2026, its #97 holding.
  • Janus Henderson Group first reported a position in United Therapeutics in Q2 2015 and has held it in 43 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.